← back to search

Anis A. Khan

Ayub Medical College · PK
Area of research
Oncology · Hepatology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Hepatocellular Carcinoma Treatment and Prognosis, Respiratory viral infections research, and Toxoplasma gondii Research Studies.
h-index
24
citations
2,807
works
94
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors
Cancer Immunology Immunotherapy 2023cited by 97position: middledoi
Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors
Journal of Pancreatic Cancer 2020cited by 49position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2023–2023)Hedy L. Kindler · Public Health Ontario1 papers (2020–2020)Yu Jiang · South China Agricultural University1 papers (2023–2023)Dong-Wan Kim · Korea University1 papers (2023–2023)— · 1 papers (2020–2020)Yuling Wu · Xiamen University1 papers (2023–2023)Sang-We Kim · Université Grenoble Alpes1 papers (2023–2023)— · 1 papers (2020–2020)Dan Wang · People 's Hospital of Jilin Province1 papers (2020–2020)Michael J. Overman · The University of Texas MD Anderson Cancer Center1 papers (2023–2023)John H. Strickler · Cancer Institute (WIA)1 papers (2023–2023)Andrea Wang‐Gillam · Washington University in St. Louis1 papers (2020–2020)— · 1 papers (2023–2023)Anne M. Noonan · U-M Rogel Cancer Center1 papers (2023–2023)Minal Barve · Mary Crowley Cancer Research Center1 papers (2023–2023)Thomas J. George · University of Florida Health1 papers (2023–2023)Peter Grimison · Migration Institute of Australia1 papers (2023–2023)— · 1 papers (2020–2020)Johanna C. Bendell · Roche (Switzerland)1 papers (2023–2023)Mythili Koneru · 490 BioTech (United States)1 papers (2020–2020)